According to Bloomberg.com, Mexico’s Genomma Lab Internacional SAB rose the most in July as Chief Executive Officer Rodrigo Herrera said the company was on pace to meet its sales growth projections this year.
The drug company is “comfortable” with the forecast of net sales growth of 5.2 percent in 2015, Herrera said in a phone interview with Bloomberg.com on Friday July 17th.
Its fourth-quarter results shocked shareholder Westwood International Advisors Inc., according to Richard Dolhun, an analyst at the firm. Genomma is due to publish its second-quarter earnings and hold a conference call with investors this week.
“We’re going to hold their feet to the fire,” Dolhun, whose firm oversees $5 billion in equities including Genomma, said by phone. “They have to have a tight message. They have to hit on what they’ve promised.”
Shares of Genomma increased 3.1 percent to 16.29 pesos at 12:35 p.m. in Mexico City. The benchmark IPC equity index rose 0.6 percent on Monday July 20th.
more recommended stories
Austrian Symphony Orchestra will arrive in Yucatan in 2019
The University of Graz-Austria Symphony Orchestra.
Patient from Mérida’s Psychiatric Hospital steals delivery truck and smashes it into a wall
On Tuesday December 12th, a patient.
Mayor walks the streets of Progreso to meet citizen requests
Progreso Mayor Julián Zacarías Curi, accompanied.
The ‘hidden jewel’ of Yucatan that you must visit
Valladolid was named one of the.
New Arrivals on Netflix Mexico in December
December looks great on Netflix. The.
UNAM promotes creation of hummingbird gardens in order to improve ecology
Hummingbirds have a great ecological importance.
Mérida’s soccer team was bought years ago with money from the Sinaloa Cartel
Tirso ‘El Futbolista‘ Martinez Sanchez, a.
Five Haciendas, five different worlds in Yucatán and Campeche
The taste, history and culture of.
Mérida wins national award for “Paseo de las Ánimas”
Due to the maintaince and promotion.
Why Trump Appears When You Google “Idiot”?
Why is Donald Trump dominating Google.